Sarat Chandarlapaty

Assistant Member, Human Oncology and Pathogenesis Program; Department of Medicine, Memorial Sloan Kettering Cancer Center

Sarat Chandarlapaty

Assistant Member, Human Oncology and Pathogenesis Program; Department of Medicine, Memorial Sloan Kettering Cancer Center
Share
Share

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Sarat Chandarlapaty discloses the following relationships and financial interests:

  • Breast Cancer Research Foundation
    Provision of Services
  • Eli Lilly and Company
    Provision of Services
  • Global Breast Cancer Conference
    Provision of Services (uncompensated)
  • Inivata, Inc.
    Provision of Services
  • Korean Society for Medical Oncology (KSMO)
    Provision of Services
  • Novartis
    Provision of Services
  • Sanofi US Services Inc.
    Provision of Services
  • Targeted Oncology
    Provision of Services
  • The Japanese Breast Cancer Society
    Provision of Services
  • Totus Medicines Inc.
    Ownership / Equity Interests

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures